会计年度:2014-06-30收入分布
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 调拨 | 1,273,911,877.56 | 1,258,143,005.88 | 15,768,871.68 | 1.24 |
| 国际贸易 | 3,400,035,307.22 | 3,093,815,408.58 | 306,219,898.64 | 9.01 |
| 化学制剂 | 523,894,020.20 | 256,752,762.61 | 267,141,257.59 | 50.99 |
| 内部抵消 | -233,255,270.36 | -232,235,436.93 | -1,019,833.43 | 0.44 |
| 其中：纯销 | 3,122,873,759.72 | 2,826,614,232.00 | 296,259,527.72 | 9.49 |
| 其中：原料药 | 614,697,646.75 | 522,429,072.35 | 92,268,574.40 | 15.01 |
| 医药工业 | 1,153,175,667.62 | 788,268,984.96 | 364,906,682.66 | 31.64 |
| 医药商业 | 4,396,785,637.28 | 4,084,757,237.88 | 312,028,399.40 | 7.10 |
| 中成药 | 14,584,000.67 | 9,087,150.00 | 5,496,850.67 | 37.69 |
|
会计年度:2013-12-31
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 调拨 | 1,309,736,777.15 | 1,275,435,344.18 | 34,301,432.97 | 2.62 |
| 国际贸易 | 5,481,710,921.79 | 4,818,158,318.45 | 663,552,603.34 | 12.10 |
| 化学制剂 | 954,533,195.07 | 513,936,153.45 | 440,597,041.62 | 46.16 |
| 内部抵消 | -363,207,425.64 | -357,955,459.01 | -5,251,966.63 | 1.45 |
| 其中：纯销 | 6,225,654,153.89 | 5,706,061,229.26 | 519,592,924.63 | 8.35 |
| 其中：原料药 | 1,153,392,372.52 | 963,069,296.43 | 190,323,076.09 | 16.50 |
| 医药工业 | 2,132,503,698.59 | 1,494,543,123.99 | 637,960,574.60 | 29.92 |
| 医药商业 | 7,535,390,931.04 | 6,981,496,573.44 | 553,894,357.60 | 7.35 |
| 中成药 | 24,578,131.00 | 17,537,674.11 | 7,040,456.89 | 28.65 |
|
会计年度:2013-06-30
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 国际贸易 | 2,892,688,955.00 | 2,530,310,763.00 | 362,378,191.00 | 12.53 |
| 合并抵消 | 161,879,090.00 | 161,879,090.00 | -- | -- |
| 医药工业-原料药 | 44,134,235.00 | 34,300,006.00 | 9,834,230.00 | 22.28 |
| 医药工业-制剂 | 129,140,093.00 | 75,434,833.00 | 53,705,260.00 | 41.59 |
| 医药商业-纯销 | 2,003,059,357.00 | 1,807,654,999.00 | 195,404,358.00 | 9.76 |
| 医药商业-调拨 | 422,066,277.00 | 412,405,527.00 | 9,660,750.00 | 2.29 |
|
会计年度:2012-12-31
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 国际贸易 | 5,732,655,386.00 | 5,122,910,003.00 | 609,745,382.00 | 10.64 |
| 合计 | 9,889,329,107.00 | 8,800,993,631.00 | 1,088,335,476.00 | 11.01 |
| 内部抵消 | 365,400,634.00 | 365,400,634.00 | -- | -- |
| 医药工业-化学制剂 | 241,423,896.00 | 135,418,063.00 | 106,005,834.00 | 43.91 |
| 医药工业-原料药 | 101,506,142.00 | 80,305,522.00 | 21,200,621.00 | 20.89 |
| 医药商业-纯销 | 3,521,501,161.00 | 3,183,503,836.00 | 337,997,325.00 | 9.60 |
| 医药商业-调拨 | 657,643,156.00 | 644,256,842.00 | 13,386,314.00 | 2.04 |
|
会计年度:2012-06-30
|
| 项目名称 | 主营业务收入 | 主营业务成本 | 主营业务毛利 | 毛利率 |
| 国际贸易 | 2,120,240,003.00 | 1,844,074,037.00 | 276,165,966.00 | 13.03 |
| 医药工业 | 144,783,332.00 | 78,200,403.00 | 66,582,929.00 | 45.99 |
| 医药商业 | 2,176,236,134.00 | 1,975,830,839.00 | 200,405,294.00 | 9.21 |
|
4/9 转到 
